Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

STOUGHTON, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report third quarter 2025 financial results before the market opens...
October 22, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

STOUGHTON, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have poster presentations highlighting real-world data from its...
October 13, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

STOUGHTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management team will ring the Nasdaq opening bell on October 14, 2025 at...
August 28, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025...
August 25, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain...
August 07, 2025 07:30 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

– Generated Record Quarterly Net Revenue of $188.0 Million, Up 29% Year-over-Year – – Generated Record Quarterly Jornay PM® Net Revenue of $32.6 Million and Grew Prescriptions by 23%...
July 24, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

STOUGHTON, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report second quarter 2025 financial results before the market opens...
July 07, 2025 08:00 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces $150 Million Share Repurchase Program

STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living...
May 19, 2025 16:01 ET | Source: Collegium Pharmaceutical, Inc.

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Mizuho...
May 12, 2025 08:05 ET | Source: Collegium Pharmaceutical, Inc.

Collegium Announces $25 Million Accelerated Share Repurchase Program

STOUGHTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living...